Paper25758053
Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
Wang S and 5 others. Tumour Biol, 2015. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy. Papers, record 25758053. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25758053
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Nuclear | Major topic |
| Biomarkers, Tumor | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| DNA-Binding Proteins | Major topic |
| Esophageal Neoplasms | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Adult | |
| Aged | |
| Disease-Free Survival | |
| Esophageal Squamous Cell Carcinoma | |
| Esophagectomy | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Ku Autoantigen | |
| Lymphatic Metastasis | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Prognosis |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10755664 | Ku autoantigen: a multifunctional DNA-binding protein. | Crit Rev Biochem Mol Biol | 2000 | https://conductscience.org/library/papers/10755664 | PubMed |
| 2 | 25368522 | Downregulated Ku70 and ATM associated to poor prognosis in colorectal cancer among Chinese patients. | Onco Targets Ther | 2014 | https://conductscience.org/library/papers/25368522 | PubMed |
| 3 | 19463580 | Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? | Ann Thorac Surg | 2009 | https://conductscience.org/library/papers/19463580 | PubMed |
| 4 | 23932191 | Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression. | Radiother Oncol | 2013 | https://conductscience.org/library/papers/23932191 | PubMed |
| 5 | 15009981 | [A study of correlation between early postoperative relapse with lymph node micrometastasis in patients with N0 esophageal cancer]. | Zhonghua Wai Ke Za Zhi | 2004 | https://conductscience.org/library/papers/15009981 | PubMed |
| 6 | 25528020 | Biological and clinical significance of PARP1 protein expression in breast cancer. | Breast Cancer Res Treat | 2015 | https://conductscience.org/library/papers/25528020 | PubMed |
| 7 | 18403903 | ShRNA-mediated Ku80 gene silencing inhibits cell proliferation and sensitizes to gamma-radiation and mitomycin C-induced apoptosis in esophageal squamous cell carcinoma lines. | J Radiat Res | 2008 | https://conductscience.org/library/papers/18403903 | PubMed |
| 8 | 23624778 | Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer. | Breast Cancer Res Treat | 2013 | https://conductscience.org/library/papers/23624778 | PubMed |
| 9 | 11152690 | Dimerization and nuclear localization of ku proteins. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11152690 | PubMed |
| 10 | 10786799 | Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. | Nature | 2000 | https://conductscience.org/library/papers/10786799 | PubMed |
| 11 | 19327566 | Environmental causes of esophageal cancer. | Gastroenterol Clin North Am | 2009 | https://conductscience.org/library/papers/19327566 | PubMed |
| 12 | 15385961 | The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9. | EMBO J | 2004 | https://conductscience.org/library/papers/15385961 | PubMed |
| 13 | 12460917 | Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. | Cancer Res | 2002 | https://conductscience.org/library/papers/12460917 | PubMed |
| 14 | 23868020 | Characterization of estrogen response element binding proteins as biomarkers of breast cancer behavior. | Clin Biochem | 2013 | https://conductscience.org/library/papers/23868020 | PubMed |
| 15 | 12216085 | The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. | Cancer | 2002 | https://conductscience.org/library/papers/12216085 | PubMed |
| 16 | 18926712 | Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus. | Eur J Cardiothorac Surg | 2009 | https://conductscience.org/library/papers/18926712 | PubMed |
| 17 | 23818566 | Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System. | Eur J Cardiothorac Surg | 2013 | https://conductscience.org/library/papers/23818566 | PubMed |
| 18 | 23181744 | Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance. | J Exp Clin Cancer Res | 2012 | https://conductscience.org/library/papers/23181744 | PubMed |
| 19 | 16682732 | Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/16682732 | PubMed |
| 20 | 24046121 | Proposed modification of the seventh American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma in Chinese patients. | Ann Surg Oncol | 2014 | https://conductscience.org/library/papers/24046121 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27639386 | Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review. | Tumour Biol | 2016 | https://conductscience.org/library/papers/27639386 | PubMed |
| 27148416 | High expression of cyclooxygenase 2 is an indicator of prognosis for patients with esophageal squamous cell carcinoma after Ivor Lewis esophagectomy. | Thorac Cancer | 2016 | https://conductscience.org/library/papers/27148416 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| XRCC5 | 7520 | PubTator's text mining | https://conductscience.org/library/genes/7520 | NCBI Gene |
| XRCC6 | 2547 | PubTator's text mining | https://conductscience.org/library/genes/2547 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25758053
GET https://conductscience.org/api/papers/v1/25758053/references?page=2